Acta academica karviniensia 2014, 14(2):149-157 | DOI: 10.25142/aak.2014.036

PHARMACEUTICAL PRICE REGULATION IN THE THEORY OF REDISTRIBUTION SYSTEMS

Veronika Svatošová1, Jan Žahour2, Zita Košnarová3, Bohuslav Sekerka4
1 University of Pardubice, Faculty Economics and Administration, Studentská 84, 532 10 Pardubice, Email: veronika.svatosova@upce.cz
2 University of Pardubice, Faculty Economics and Administration, Studentská 84, 532 10 Pardubice, Email: jzahour@seznam.cz
3 University of Pardubice, Faculty Economics and Administration, Studentská 84, 532 10 Pardubice, Email: zita.kosnarova@upce.cz
4 University of Pardubice, Faculty Economics and Administration, Studentská 84, 532 10 Pardubice, Email: bohuslav.sekerka@upce.cz

Nowadays, a firm has to, not only, follow the outside environment and predominantly its field environment where it constantly maps customers' behaviour, but the firm has to also perceive the inside environment. Firm price making represents the key role. This paper describes pharmaceutical market and its rules of price making. As remedies should be available to anyone, it is obvious that the market is regulated by state. Products are divided into groups according to their prices. The groups are identified by the highest possible percentage of margin that can be made by a particular product. On the basis of publicly available data this paper analyses behaviour of producers and distributors and looks for similar characteristics of such behaviour. The goal of this article is to analyse current pharmaceutical market in relation with regulated prices and on this basis to describe optimal profit margin on this market. Today's economy results from more or less theoretical findings that cannot be fully compatible with economic reality. This situation is illustrated by game theory and consequently arising theory of redistribution systems. When creating theoretical visions, it is necessary to go basically from known patterns of real economy. This paper is also focused on practical usage of game theory and theory of redistribution systems on pharmaceutical market through research of redistribution of regulated margin between various subjects of supply chain.

Keywords: optimal profit margin, pharmaceutical market, profit margin, regulated margin, theory of redistribution systems
JEL classification: D49, L50, M29

Received: October 7, 2011; Accepted: June 16, 2014; Published: June 30, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svatošová V, Žahour J, Košnarová Z, Sekerka B. PHARMACEUTICAL PRICE REGULATION IN THE THEORY OF REDISTRIBUTION SYSTEMS. Acta academica karviniensia. 2014;14(2):149-157. doi: 10.25142/aak.2014.036.
Download citation

References

  1. AYSEGUL, T., 2007. The Single Market and Pharmaceutical Industry in the European Union: Is There Any Evidence of Price Convergence? Florida: University of South Florida. 167 p. Dissertation.
  2. BUDINSKÝ, P. a R. VALENČÍK, 2009. Teorie redistribučních systémů [online]. Praha: Vysoká škola finanční a správní [vid. 2011-04-17]. Available from: <www.vse.cz/polek/download.php?jnl=polek&pdf=702.pdf>.
  3. DAVIDOVÁ, J. et al., 2008. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden. Pharm World Sci. 9 p. DOI 10.1007/s11096-007-9141-z.
  4. FUCHS, K., 1999. Cena, hodnotová teorie a soudobá ekonomie. Acta Academica Karviniensa, 2, 22 - 28. ISSN 1212 415X.
  5. GOLEC, J. and J. A. VERNON, 2010. Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms. Pharmaeconomics, 28(8), 15. ISSN 615-628-1170-7690. Go to original source...
  6. GOLEC, J., J. A. VERNON and W. K. HUGHEN, 2006. The Economics of Pharmaceutical Price Regulation and Importation: Refocusing the Debate. American Journal of Law & Medicine, 32(2), 18. ISSN 0098-8588. Go to original source...
  7. MHCZ : Ministry of Health of the Czech Republic. Informace o úhradách, cenách a výši případného doplatku léčivých přípravků [online]. 2011. [vid. 2011-03-20]. Available from: <http://www.mzcr.cz/leky.aspx>.
  8. PASEKOVÁ, M., 2005. Mikroekonomické aspekty hospodaření malých a středních podniků. E+M Ekonomie a management, 8(1), 6 - 11. ISSN 1212-3609.
  9. Pearson Education. Market Equilibrium Demand. Supply and Market Equilibrium [online]. 2010. [vid. 2011-04-29]. Available from: http://wps.prenhall.com/bp_casefair_econf_7e/30/7931/2030537.cw/index.html>.
  10. Pharmacy Napravil. Jak se tvoří konečná cena léků [online]. 2011. [vid. 2011-03-20]. Available from: <http://www.lekarna-napravil.cz/13-o-nas/35-jak-se-tvori-konecna-cena-leku>.
  11. RENESCH, J. a R. VALENČÍK, 2010. Možnosti aplikace teorie redistribučních systémů jako součásti knowledge managementu [online]. Praha: Vysoká škola finanční a správní. [vid. 2011-04-17]. Available from: <www.vsfs.cz/soubor.php?s=rozvojfirmyatrs.doc&adr=epssi>.
  12. SEDLÁČEK, J. a P. VALOUCH, 2009. Reálná hodnota v cenové regulaci přirozeného monopolu. E+M Ekonomie a management, 12(2), 6 - 14. ISSN 1212-3609.
  13. SIDC: State Institute for Drug Control. Lékárny a léčiva [online]. 2011. [vid. 2011-03-20]. Available from: <http://www.sukl.cz/modules/medication/search.php>.
  14. VALENČÍK, R., 2008. Teorie her (redistribučních systémů) jako bojové umění [online]. Praha: Vysoká škola finanční a správní. [vid. 2011-04-17]. Available from: <www.vsfs.cz/soubor.php?s=trs-vyber.doc&adr=epssi>.
  15. WIGGINS, S. N. and R. MANESS, 2004. Price Competition in Pharmaceuticals: The Case of Anti-infectives. Economic Inquiry, 42(2), 247-263. ISSN 0095-2583. Go to original source...
  16. XIA, L., 2005. Memory distortion and consumer price knowledge. The Journal of Product and Brand Management, 14(5), 338 - 347. ISSN 1061 - 0421. Go to original source...